Purdue Pharma agrees to $7.4B opioid settlement with states
Digest more
All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.
A linguistic loophole could put an estimated $250 million opioid settlement payout in jeopardy due to New York for addiction treatment, prevention and recovery programs.
Explore more